Insider trading activities (stock purchases, sales, and option exercises)
reported by insiders of Checkpoint Therapeutics, Inc. (CKPT)
since 2018 are shown in Table 1 and Table 2.
Table 1 shows the monthly insider trading data of Checkpoint Therapeutics, Inc..
Table 2 shows the detailed insider transactions.
This company's CIK number is 1651407.
Total stock buying since 2018: $356,211.
Total stock sales since 2018: $6,262,483.
Total stock option exercises since 2018: $0.
Table 3. Detailed insider trading at Checkpoint Therapeutics, Inc. (CKPT)
| Trade Date |
Insider Name |
Trade Type |
Shares |
Price ($) |
Value ($) |
| 2025-05-29 | Fortress Biotech, Inc. | Sale | 100,000 | 1.29 | 129,000 |
| 2025-04-02 | Oliviero James F Iii (CEO, President and Director) | Sale | 15,090 | 4.04 | 60,963 |
| 2025-04-01 | Gray William Garrett (Chief Financial Officer) | Sale | 12,322 | 4.05 | 49,904 |
| 2025-02-10 | Oliviero James F Iii (CEO, President and Director) | Sale | 10,331 | 3.15 | 32,542 |
| 2025-02-07 | Oliviero James F Iii (CEO, President and Director) | Sale | 9,233 | 3.41 | 31,484 |
| 2025-02-06 | Gray William Garrett (Chief Financial Officer) | Sale | 74,110 | 3.67 | 271,983 |
| 2024-12-19 | Oliviero James F Iii (CEO, President and Director) | Sale | 220,230 | 3.38 | 744,377 |
| 2024-12-18 | Gray William Garrett (Chief Financial Officer) | Sale | 268,432 | 4.01 | 1,076,412 |
| 2024-12-18 | Oliviero James F Iii (CEO, President and Director) | Sale | 602,167 | 3.87 | 2,330,386 |
| 2024-06-26 | Gray William Garrett (Chief Financial Officer) | Sale | 13,038 | 2.06 | 26,858 |
| 2024-06-26 | Oliviero James F Iii (CEO, President and Director) | Sale | 24,610 | 2.05 | 50,450 |
| 2024-02-28 | Gray William Garrett (Chief Financial Officer) | Sale | 2,035 | 2.07 | 4,212 |
| 2024-02-28 | Oliviero James F Iii (CEO, President and Director) | Sale | 5,894 | 2.06 | 12,141 |
| 2024-02-01 | Gray William Garrett (Chief Financial Officer) | Sale | 4,115 | 1.95 | 8,024 |
| 2024-02-01 | Oliviero James F Iii (CEO, President and Director) | Sale | 11,900 | 2.01 | 23,918 |
| 2023-03-02 | Gray William Garrett (Chief Financial Officer) | Sale | 3,591 | 5.00 | 17,955 |
| 2023-03-02 | Oliviero James F Iii (CEO, President and Director) | Sale | 5,483 | 5.00 | 27,415 |
| 2023-02-27 | Gray William Garrett (Chief Financial Officer) | Sale | 1,914 | 4.66 | 8,919 |
| 2023-02-27 | Oliviero James F Iii (CEO, President and Director) | Sale | 5,548 | 4.65 | 25,798 |
| 2023-02-01 | Gray William Garrett (Chief Financial Officer) | Sale | 3,154 | 4.79 | 15,107 |
| 2023-02-01 | Oliviero James F Iii (CEO, President and Director) | Sale | 10,261 | 4.77 | 48,944 |
| 2023-01-10 | Gray William Garrett (Chief Financial Officer) | Sale | 1,858 | 6.75 | 12,539 |
| 2023-01-10 | Oliviero James F Iii (CEO, President and Director) | Sale | 3,817 | 6.75 | 25,760 |
| 2022-06-23 | Oliviero James F Iii (CEO, President and Director) | Sale | 15,000 | 1.11 | 16,650 |
| 2022-06-22 | Oliviero James F Iii (CEO, President and Director) | Sale | 12,000 | 1.09 | 13,080 |
| 2022-06-21 | Oliviero James F Iii (CEO, President and Director) | Sale | 21,000 | 1.09 | 22,890 |
| 2022-06-17 | Oliviero James F Iii (CEO, President and Director) | Sale | 228,000 | 1.09 | 248,520 |
| 2022-04-13 | Oliviero James F Iii (CEO, President and Director) | Sale | 21,258 | 1.51 | 32,099 |
| 2022-04-05 | Oliviero James F Iii (CEO, President and Director) | Sale | 14,030 | 1.77 | 24,833 |
| 2022-04-04 | Oliviero James F Iii (CEO, President and Director) | Sale | 86,353 | 1.79 | 154,571 |
| 2022-03-10 | Gray William Garrett (Chief Financial Officer) | Sale | 38,197 | 1.89 | 72,306 |
| 2022-02-01 | Gray William Garrett (Chief Financial Officer) | Sale | 37,063 | 2.51 | 92,954 |
| 2021-02-05 | Oliviero James F Iii (CEO, President and Director) | Sale | 48,790 | 3.42 | 166,764 |
| 2021-02-04 | Gray William Garrett (Chief Financial Officer) | Sale | 26,320 | 3.66 | 96,331 |
| 2021-02-04 | Oliviero James F Iii (CEO, President and Director) | Sale | 70,000 | 3.51 | 245,560 |
| 2020-12-22 | Gray William Garrett (Chief Financial Officer) | Sale | 2,406 | 2.79 | 6,712 |
| 2020-05-21 | Gray William Garrett (See Remarks) | Sale | 17,104 | 2.00 | 34,122 |
| 2019-11-20 | Rosenwald Lindsay A Md | Buy | 100,000 | 1.27 | 127,000 |
| 2018-11-09 | Rosenwald Lindsay A Md | Buy | 49,666 | 2.35 | 116,715 |
| 2018-11-08 | Rosenwald Lindsay A Md | Buy | 48,234 | 2.24 | 108,044 |
| 2018-11-07 | Rosenwald Lindsay A Md | Buy | 2,100 | 2.12 | 4,452 |
Insider trading activities including stock purchases, stock sales, and option exercises
of CKPT listed in the above tables cannot be completely guaranteed as to their accuracy.
For more insider trading information of Checkpoint Therapeutics, Inc. (symbol CKPT,
CIK number 1651407) see
the Securities and Exchange Commission (SEC) website.